Analysts Set Mettler-Toledo International Inc. (NYSE:MTD) Price Target at $1,304.25

Shares of Mettler-Toledo International Inc. (NYSE:MTD) have been given an average rating of “Hold” by the nine ratings firms that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $1,304.25.

Several brokerages recently commented on MTD. Evercore ISI lifted their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a report on Monday, February 10th. Wells Fargo & Company reduced their price target on shares of Mettler-Toledo International from $1,400.00 to $1,125.00 and set an “equal weight” rating for the company in a research report on Thursday, April 17th. Citigroup raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 price objective on the stock in a report on Monday, April 7th. Finally, Robert W. Baird reduced their target price on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a “neutral” rating for the company in a report on Tuesday, April 22nd.

Insider Activity

In related news, insider Gerry Keller sold 600 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the transaction, the insider now directly owns 6 shares of the company’s stock, valued at approximately $8,108.04. The trade was a 99.01 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Christian Magloth sold 790 shares of the stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the sale, the insider now directly owns 734 shares of the company’s stock, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. GAMMA Investing LLC grew its holdings in Mettler-Toledo International by 131,246.3% during the 1st quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier’s stock valued at $456,018,000 after buying an additional 385,864 shares in the last quarter. Norges Bank purchased a new position in shares of Mettler-Toledo International in the fourth quarter valued at $372,954,000. Proficio Capital Partners LLC bought a new stake in Mettler-Toledo International in the fourth quarter worth $163,216,000. T. Rowe Price Investment Management Inc. raised its stake in Mettler-Toledo International by 36.1% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier’s stock valued at $444,327,000 after purchasing an additional 96,300 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its position in Mettler-Toledo International by 53.0% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 214,281 shares of the medical instruments supplier’s stock valued at $262,211,000 after purchasing an additional 74,187 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

Shares of NYSE:MTD opened at $1,056.35 on Friday. The business has a 50-day simple moving average of $1,141.00 and a two-hundred day simple moving average of $1,235.97. The firm has a market cap of $22.02 billion, a price-to-earnings ratio of 26.06, a price-to-earnings-growth ratio of 3.30 and a beta of 1.28. Mettler-Toledo International has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, beating analysts’ consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. During the same quarter in the prior year, the business earned $8.89 EPS. The company’s revenue was down 4.6% compared to the same quarter last year. As a group, research analysts predict that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.